Cargando…

Correction to: Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France

Detalles Bibliográficos
Autores principales:	Mezaache, Salim, Carrieri, Patrizia, Briand‑Madrid, Laelia, Laporte, Virginie, Morel, Alain, Castro, Daniela Rojas, Roux, Perrine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893719/ https://www.ncbi.nlm.nih.gov/pubmed/33607993 http://dx.doi.org/10.1186/s12954-021-00465-9

Ejemplares similares

Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
por: Mezaache, Salim, et al.
Publicado: (2021)

Willingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France
por: Roux, Perrine, et al.
Publicado: (2017)

A two-component intervention to improve hand hygiene practices and promote alcohol-based hand rub use among people who inject drugs: a mixed-methods evaluation
por: Mezaache, Salim, et al.
Publicado: (2021)

Fulminant hepatic failure after intravenous injection of sublingual buprenorphine in a patient with hepatitis C
por: French, Janine, et al.
Publicado: (2015)

Changes in cannabis use and associated correlates during France’s first COVID-19 lockdown in daily cannabis users: results from a large community-based online survey
por: Mezaache, Salim, et al.
Publicado: (2022)

Post-operative Analgesia in Opioid Dependent Patients: Comparison of Intravenous Morphine and Sublingual Buprenorphine
por: Alizadeh, Shaabanali, et al.
Publicado: (2015)

Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects
por: Hagelberg, Nora M., et al.
Publicado: (2016)

Comparison of sublingual buprenorphine and intravenous morphine in reducing bone metastases associated pain in cancer patients
por: Jamalian, Seyed Mohammad, et al.
Publicado: (2019)

Pharmacokinetics of buprenorphine in pregnant sheep after intravenous injection
por: Hakomäki, Henriikka, et al.
Publicado: (2021)

Postoperative respiratory depression in patients on sublingual buprenorphine: a retrospective cohort study for comparison between postoperative continuation and discontinuation of buprenorphine
por: Komatsu, Ryu, et al.
Publicado: (2022)

Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol
por: Auriacombe, Marc, et al.
Publicado: (2019)

New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
por: Soyka, Michael
Publicado: (2015)

Sublingual Buprenorphine: A Feasible Alternative for Treating Breakthrough Chronic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019)

A randomized controlled study to compare analgesic efficacy of sublingual buprenorphine and intravenous tramadol in patients undergoing mastectomy
por: Dokku, Krishna Sumanth, et al.
Publicado: (2022)

Buprenorphine
por: Mazurek, Jaroslaw, et al.
Publicado: (2014)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Effectiveness of Sublingual Buprenorphine and Fentanyl Pump in Controlling Pain After Open Cholecystectomy
por: Norozi, Vadood, et al.
Publicado: (2021)

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
por: Lee, Joshua D., et al.
Publicado: (2021)

Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
por: Martin, Yvette N., et al.
Publicado: (2019)

2198: Gender differences in the pharmacology of buprenorphine sublingual tablets in Hispanics/Latinos: An underrepresented population
por: Ivelisse Santiago, Darlene, et al.
Publicado: (2018)

Sublingual Buprenorphine/Naloxone and Multi-Modal Management for High-Risk Chronic Pain Patients
por: Kaski, Shane, et al.
Publicado: (2021)

Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film
por: Gunderson, Erik W., et al.
Publicado: (2016)

A novel approach in the detoxification of intravenous buprenorphine dependence
por: Sarkar, Sukanto, et al.
Publicado: (2016)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
por: Björnsson, Marcus, et al.
Publicado: (2023)

Pharmaceutical and pharmacokinetic characterization of a novel sublingual buprenorphine/naloxone tablet formulation in healthy volunteers
por: Fischer, Andreas, et al.
Publicado: (2015)

Extended-release monthly buprenorphine injection
por: Cuperfain, Ari B., et al.
Publicado: (2023)

Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone
por: Marsden, John, et al.
Publicado: (2022)

Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation
por: Lowry, Natalie, et al.
Publicado: (2022)

BUPRENORPHINE WITHDRAWAL SYNDROME
por: Tripathi, B.M., et al.
Publicado: (1995)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine
por: Bormann, Nicholas L., et al.
Publicado: (2023)

Sublingual buprenorphine for acute renal colic pain management: a double-blind, randomized controlled trial
por: Payandemehr, Pooya, et al.
Publicado: (2014)

Sublingual Buprenorphine Efficacy in Renal Colic Pain Relief: A Randomized Placebo-Controlled Clinical Trial
por: Mozafari, Javad, et al.
Publicado: (2017)

Sublingual Buprenorphine and Methadone Maintenance Treatment: A Three-Year Follow-Up of Quality of Life Assessment
por: Giacomuzzi, Salvatore M., et al.
Publicado: (2005)

The effect of preoperative sublingual buprenorphine on postoperative pain after lumbar discectomy: A randomized controlled trial
por: Kiabi, Farshad Hassanzadeh, et al.
Publicado: (2021)

Pharmacokinetics of intravenous, oral transmucosal, and intranasal buprenorphine in healthy male dogs
por: Enomoto, Hiroko, et al.
Publicado: (2022)

Pharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder
por: Dong, Ruihua, et al.
Publicado: (2019)

Pharmacokinetic Characterization and External Evaluation of a Quantitative Framework of Sublingual Buprenorphine in Patients with an Opioid Disorder in Puerto Rico
por: Santiago, Darlene, et al.
Publicado: (2020)

Submission for: Poster presentation at ANCIPS 2022: Allergic dermatitis with use of sublingual Buprenorphine: A rare case report
por: Gracy*, Dr BK, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o1vjb232b2il75e68ok4p8t3ai